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Abstract: 
Enterohemorrhagic Escherichia coli (EHEC) are source of emerging infectious disease in India. Escherichia coli O157:H7 is an 
EHEC strain showing multiple antibiotic resistances and the cause of infantile diarrhea and hemolytic uremic syndrome worldwide. 
A novel strategy to counteract multiple antibiotic resistant organisms is to design drugs which specifically target metabolic 
pathways such as thiamine biosynthetic pathways found exclusively in prokaryotes. Homology modeling was used for model 
building of a terminal thiamine biosynthesis enzyme phosphoryl thymidine kinase (Thi E) using Geno3D, Swiss Model and 
Modeller. The best model was selected based on overall stereochemical quality. The potential ligand binding sites in the model 
were identified by CASTp server. The validated theoretical model of the 3D structure of the thiE protein of E. coli O157:H7 was 
predicted using a thiamine phosphate pyrophosphatase from Pyrococcus furiosus (PDB ID: 1X13_A) as template. The active 
pockets of ligand binding sites in the enzyme were identified. In this study, phosphoryl thymidine kinase (thi E), a terminal enzyme 
in the thiamine biosynthesis pathway in the pathogen has been modeled to be used in future as a potential drug target by the design 
of suitable inhibitors.  
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Background: 
Enterohemorrhagic  Escherichia coli (EHEC) are a group of 
Gram Negative bacteria belonging to Enterobacteriaceae family 
that are a significant cause of infantile diarrhea and hemolytic 
uremic syndrome in the developing and developed nations [1]. 
Infections are usually transmitted following ingestion of 
unhygienic packed and processed food, milk and water 
resources. One typical EHEC, Escherichia coli O157:H7, also 
known as verotoxigenic Escherichia coli (E. coli) or shiga like 
toxin producing E coli, is the causative agent of hemorrhagic 
colitis [1]. These organisms have been characterized to produce 
virulence factors like periplasmic catalases and shiga-like 
toxins which act by catalytically inactivating 60S ribosomal 
subunit of the eukaryotic protein translation machinery [1, 2]. 
The verotoxin it self is expressed by a prophage carried by the 
E.coli strains. The periplasmic catalase is plasmid mediated 
(pO157 plasmid) and provides oxidative protection during 
infection. E coli O157:H7 fail to show pathogenicity factors 
seen in other pathogenic E coli and hence cannot be cultured on 
plates containing bile salts [2]. As a consequence, studies on 
these hemorrhagic pathogens have been limited and effective 
means of preventing EHEC have not been elucidated.  
 
E coli O157:H7 was first indicated in food borne illness in the 
USA in 1982 [1]. In India, the emergence of infections with E 
coli O157:H7 was first reported in 1999 by Pal and colleagues 
[3]. A comprehensive review of the molecular epidemiology of 
E coli O157:H7 in India is reported by Wani and colleagues [4]. 
The recent emergence of this infectious EHEC as a biofilm 
former has further marked it for increased multiple antibiotic 
resistances and made it imperative that new strategies should be 
investigated to curb such infections [1]. One such strategy for 
novel drug design is targeting metabolic pathways present 
exclusively in prokaryotes. Vitamin biosynthesis pathways in 
prokaryotes that are absent in vertebrates provide such an 
opportune metabolism. The thiamine (Vitamin B1) biosynthesis 
pathway represents a pathway that has been outlined for 
Escherichia coli as represented in Figure 1 and derived from 
MetaCyc database [5]. Thiazole (5-methyl-4-(β-hydroxyethyl) 
thiazole phosphate)
  and the pyrimidine (4-amino-5-
hydroxymethylpyrimidine pyrophosphate)
  moieties are 
separately synthesized. The
  pyrimidine is derived from 
5aminoimidazole ribotide. The
  thiazole is derived from 
tyrosine, cysteine,
 and 1-deoxy-D-xylulose-5-phosphate. These 
are coupled by the enzyme thiamine pyrophosphorylase kinase 
(thi E, 2.5.1.3) to form thiamine mono phosphate. A final 
phosphorylation step results in the formation of thiamine 
pyrophosphate (THI-PP) which forms the biological active 
molecule. THI-PP, the metabolically important form of vitamin Bioinformation by Biomedical Informatics Publishing Group                             open access 
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BB1 is a cofactor of α-keto acid dehydrogenase complexes, the 
glycine cleavage system and enzymes such as transketolase and 
pyruvate decarboxylase, important in carbohydrate metabolism. 
Five tightly linked genes have found to be involved in thiamine 
biosynthesis called as the thi CEFGH cluster [6]. Thi E forms 
the crucial end point enzyme in the thiamine biosynthesis from 
different precursors and can be used for as a target for 
designing drugs against E coli OH: 157 (Figure 1).  
In this report, the Thi E enzyme of the TBS pathway was 
studied in the Enterohemorrhagic Escherichia coli OH: 157 
using in silico approaches. The structural studies on the Thi E 
have not yet been elucidated. Here, the tertiary structure of the 
protein is predicted using three different protein structure 
prediction tools. The best predicted 3D model has been 
analyzed with respect to its structural features and the putative 
docking sites of the Thi E enzymes are predicted. 
 
 
Figure 1: Thiamine biosynthesis pathway for E. coli. 
 
 
Figure 2: Sequence alignment between target and template. 
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Figure 3: Potential ligand binding pocket residues in Thi E model from E. coli OH:157 
 
Methodology: 
Sequence retrieval  
The FASTA sequence of the target Thi E protein (accession 
number BAB 38339; length- 211 residues) from Escherichia 
coli O157:H7 was obtained from NCBI Entrez [7].   
 
Structure prediction and evaluation 
The modeling of the 3 D structure of the protein was performed 
by three automated homology modeling programs, Geno 3D, 
Swissmodel and Modeller [8, 9, 10]. The following steps were 
followed: template structure search using BLASTp [7]. In order 
to determine homologous sequences to the Thi E enzyme, the 
FASTA sequence was submitted for NCBI BLASTp analysis. 
Following BLASTp query, a thiamine phosphate 
pyrophosphatase from Pyrococcus furiosus (PDB ID: 1X13_A) 
was selected as template sequence [11]. The template was 
submitted to Geno3D and Swissmodel automated homology 
modeling. For Modeller, the template and target sequences were 
carefully aligned to remove potential alignment errors. The 
validation for structure models obtained from the three software 
tools was performed by using PROCHECK [12] and energy 
minimization performed by Verify3D [13]. The overall 
stereochemical quality of the protein was assessed by 
Ramchandran plot analysis [14]. The structures were visualized 
using Swiss PdBviewer v 4.0.1. 
 
Ligand binding site prediction  
An analysis of the ligand binding pockets of the predicted 
structure was performed using CASTp [15]. As determined by 
CASTp using a 1.4 Å radius probe, the internal cavity surface 
volume of the ligand binding sites was calculated. 
 
Discussion: 
The FASTA sequence of Thi E protein of E coli OH: 157 str 
Sakai was obtained from NCBI Entrez (Figure 2a). Following 
BLASTp query, a thiamine phosphate pyrophosphatase from 
Pyrococcus furiosus (PDB ID: 1X13_A) was selected as 
template sequence. This sequence showed a highest sequence 
homology of 39.3%, with atomic resolution of its X ray crystal 
structure being 1.7 A and R value being 0.189. The alignment 
obtained between Thi E and 1X13_A is shown in Figure 2. The 
1X13_A structure was used as a template for homology 
modeling by three different protein prediction tools: Geno3D, 
Swissmodel and Modeller (9v1). The predicted models were 
also checked for psi and phi torsion angles using the 
Ramchandran plots. A comparison of the results obtained from 
the three different software tools, shows that one of the models 
generated by Modeller is more acceptable in comparison to that 
by Geno3D and SwissModel (Table 1 under supplementary 
material). The molecular visualization program SWISS PDB 
viewer was used to manipulate the models based on residue 
interactions, energy minimization and steric hinderance. The 
best model predicted by Modeller was used for further analysis 
by PROCHECK [12]. Ramchandran plot analysis shows 91.8% 
of the residues in the most favored region, 6.6 % in the allowed 
and 0.5% in the disallowed region. The overall topology of the 
modeled Thi E from E. coli OH: 157 consist of seven strands 
and nine alpha helices. A TIM beta/alpha barrel fold is observed 
in the model which is typical of thiamin phosphate synthase 
superfamily. No homology with any human derived protein was 
found upon screening the BLASTP analysis. In order to 
determine the ligand binding pockets in the predicted model, 
CASTp server was used. A total of 38 ligand binding sites were 
predicted of which the first pocket was chosen based on the area 
and the volume of the pocket. The molecular structure of the 
potential active site predicted by the CASTp server was 
visualized using Swiss Pdb viewer 4.0.1 (Figure 3).  
 
Conclusion: 
The study of metabolic pathways for design of suitable targets 
against infectious agents is an effective strategy. The plethora of 
enzymes targets in different metabolic pathways remains to be 
discovered and studied as targets. A molecular model of the 
phosphoryl thymidine kinase from Enteropathogenic 
Escherichia coli OH: 157 is predicted in this study using three Bioinformation by Biomedical Informatics Publishing Group                             open access 
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different homology modeling tools. Thi E forms one of the most 
conserved parts of the TBS pathway in bacteria while no 
homology is identified upon blast analysis with humans. The 
ligand binding sites in the predicted model will provide 
valuable insights towards inhibitor design. 
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Supplementary material 
  Modeller Geno3D  Swissmodel 
Model’s Energy  -10902.722 KJ/mol  -16039.815 KJ/mol  -9108.529 KJ/mol  
Residues in the most FavoredRegion    91.8 %   71.5 %   91.6%    
Residues in additionally allowed region  6.6%  23.3%  7.2% 
Residues in generously allowed region  1.1%  4.1%  0.6% 
Residues in disallowed region 0.5%  1.2%  0.6% 
Table 1: Comparative analysis of the validated models from Modeller, Geno3D, and Swiss-model 